Thrombolex
New Britain
About Thrombolex
Thrombolex designs, develops, manufactures, and distributes innovative endovascular catheters. The company's mission is to create innovative endovascular catheters for use in the treatment of patients with arterial and venous thromboembolic (A+VTE) conditions. It allows for the selective infusion of the physician, specified fluids, including thrombolytics, into precise locations in the patient’s peripheral vasculature. Thereby treating the thrombus more efficiently in less time, using lower doses of thrombolytic drugs, thus reducing costs. Thrombolex was founded in 2016 by Michael J. Cerminaro.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $54.5M
- Last round: Series Unknown (Mar 2026)
- Website: thrombolex.com
- Phone: +1 (844) 792-6300
Industries & Categories
Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/thrombolex-135103 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.